United States · FDA National Drug Code directory
STELARA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 57894-060_30a2caf3-0c87-47a6-b087-25028ff6f8c0
- Product NDC
- 57894-060
- Form
- INJECTION, SOLUTION
- Composition / generic term
- ustekinumab
- Labeler
- Janssen Biotech, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20090925
- Source listing expiry
- 20271231
Source-listed ingredients
- USTEKINUMAB — 45 mg/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-USE in 1 CARTON (57894-060-02) / .5 mL in 1 VIAL, SINGLE-USE · 57894-060-02
- 1 SYRINGE in 1 CARTON (57894-060-03) / .5 mL in 1 SYRINGE · 57894-060-03
- 1 SYRINGE in 1 CARTON (57894-060-04) / .5 mL in 1 SYRINGE · 57894-060-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →